GHTF Adverse Event Reporting Guidance Is A Stride Toward Harmonization
This article was originally published in The Gray Sheet
Executive Summary
Adverse device side effects can go unreported as long as they are clearly identified in the manufacturer's labeling, according to a Nov. 17-posted Global Harmonization Task Force guidance document
You may also be interested in...
GHTF docs
FDA is requesting 1comments by April 25 on Global Harmonization Task Force study group documents released in 2005, including the proposed guidances, "Principles of Medical Devices Classification," "Guidelines for Regulatory Auditing of Quality Management Systems - Part 2: Regulatory Auditing Strategy" (2"The Gray Sheet" Dec. 5, 2005, p. 18). The agency is also requesting feedback on the final documents, "Information Document Concerning the Definition of the Term 'Medical Device'" and "Essential Principles of Safety & Performance of Medical Devices" (3"The Gray Sheet" Aug. 1, 2005, p. 17)...
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.